- Home
- ODD vs AMPH Comparison
ODD vs AMPH Comparison
Compare ODD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODD
- AMPH
- Stock Information
- Founded
- ODD 2018
- AMPH 1996
- Country
- ODD Israel
- AMPH United States
- Employees
- ODD N/A
- AMPH N/A
- Industry
- ODD
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- ODD
- AMPH Health Care
- Exchange
- ODD Nasdaq
- AMPH Nasdaq
- Market Cap
- ODD 2.7B
- AMPH 2.5B
- IPO Year
- ODD 2023
- AMPH 2014
- Fundamental
- Price
- ODD $48.39
- AMPH $40.85
- Analyst Decision
- ODD Buy
- AMPH Buy
- Analyst Count
- ODD 7
- AMPH 4
- Target Price
- ODD $53.29
- AMPH $60.33
- AVG Volume (30 Days)
- ODD 462.7K
- AMPH 458.4K
- Earning Date
- ODD 11-06-2024
- AMPH 11-06-2024
- Dividend Yield
- ODD N/A
- AMPH N/A
- EPS Growth
- ODD 80.44
- AMPH 17.38
- EPS
- ODD 1.64
- AMPH 3.01
- Revenue
- ODD $620,646,000.00
- AMPH $723,549,000.00
- Revenue This Year
- ODD $27.40
- AMPH $16.86
- Revenue Next Year
- ODD $20.03
- AMPH $10.07
- P/E Ratio
- ODD $29.45
- AMPH $13.58
- Revenue Growth
- ODD 29.59
- AMPH 20.33
- 52 Week Low
- ODD $30.34
- AMPH $36.56
- 52 Week High
- ODD $51.00
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- ODD 57.86
- AMPH 31.08
- Support Level
- ODD $46.32
- AMPH $43.34
- Resistance Level
- ODD $50.72
- AMPH $45.39
- Average True Range (ATR)
- ODD 2.26
- AMPH 1.31
- MACD
- ODD 0.13
- AMPH -0.23
- Stochastic Oscillator
- ODD 64.30
- AMPH 8.36
About ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.